Home068270 • KRX
add
Celltrion Inc
Nakaraang pagsara
₩162,400.00
Sakop ng araw
₩156,300.00 - ₩160,400.00
Sakop ng taon
₩152,666.67 - ₩200,952.39
Market cap
35.28T KRW
Average na Volume
451.42K
P/E ratio
77.25
Dividend yield
0.45%
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.06T | 178.01% |
Gastos sa pagpapatakbo | 347.40B | 182.95% |
Net na kita | 236.65B | 22,354.46% |
Net profit margin | 22.25 | 7,846.43% |
Kita sa bawat share | 1.15K | 13,270.00% |
EBITDA | 275.17B | 201.50% |
Aktuwal na % ng binabayarang buwis | 14.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.14T | 50.90% |
Kabuuang asset | 21.06T | 5.50% |
Kabuuang sagutin | 3.48T | 22.75% |
Kabuuang equity | 17.58T | — |
Natitirang share | 215.26M | — |
Presyo para makapag-book | 2.00 | — |
Return on assets | 2.37% | — |
Return on capital | 2.52% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 236.65B | 22,354.46% |
Cash mula sa mga operasyon | 305.93B | 104.51% |
Cash mula sa pag-invest | -101.50B | -175.12% |
Cash mula sa financing | -228.94B | -214.96% |
Net change in cash | 23.77B | -88.30% |
Malayang cash flow | 61.13B | 103.98% |
Tungkol
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
1,074
